Thomas P. Kelly
2019
In 2019, Thomas P. Kelly earned a total compensation of $2.1M as EVP, Chief Financial Officer & Treasurer at Deciphera Pharmaceuticals, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $336,690 |
|---|---|
| Option Awards | $1,308,788 |
| Salary | $430,000 |
| Other | $11,200 |
| Total | $2,086,678 |
Kelly received $1.3M in option awards, accounting for 63% of the total pay in 2019.
Kelly also received $336.7K in non-equity incentive plan, $430K in salary and $11.2K in other compensation.
Rankings
In 2019, Thomas P. Kelly's compensation ranked 5,716th out of 13,971 executives tracked by ExecPay. In other words, Kelly earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,716 out of 13,971 | 59th |
Division Manufacturing | 2,139 out of 5,701 | 63rd |
Major group Chemicals And Allied Products | 769 out of 2,200 | 65th |
Industry group Drugs | 646 out of 1,886 | 66th |
Industry Pharmaceutical Preparations | 473 out of 1,398 | 66th |
Source: SEC filing on April 24, 2020.
Kelly's colleagues
We found four more compensation records of executives who worked with Thomas P. Kelly at Deciphera Pharmaceuticals in 2019.